Alzheimer Disease

January 22nd 2024

Myloid-reducing monoclonal antibodies for patients with Alzheimer have harmful risks, such as cerebral edema, hemorrhage, serious adverse events, and death, according to a new study.

January 9th 2024

Participants with poor sleep quality were 85% more likely to have poor cognitive performance on the Stroop test than participants with good sleep quality, a new study found.

January 4th 2024

In a new study, hearing loss was significantly associated with a 7% higher risk of dementia, while hearing aids were shown to reduce such risks.

December 8th 2023

While specialists still debate the diagnostics of impaired cognition, the identification of patients at the earliest stages is beginning to be met through new biomarkers and available assays.